Retinoic acid therapy served by ligands cross linking and masking CD38.
Yen
Andrew
A
D051997:ADP-ribosyl Cyclase 1 / Q000378:metabolism*; D000943:Antigens, Differentiation / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002454:Cell Differentiation; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008024:Ligands; D018168:Receptors, Retinoic Acid; D014212:Tretinoin / Q000627:therapeutic use*
D000943:Antigens, Differentiation; D000970:Antineoplastic Agents; D008024:Ligands; D018168:Receptors, Retinoic Acid; D014212:Tretinoin; D051997:ADP-ribosyl Cyclase 1